FT Raymond James Multicap Growth Equity ETF (RJMG) is an exchange-traded fund that seeks long-term capital appreciation by investing primarily in a diversified portfolio of equity securities of U.S. companies exhibiting growth characteristics across multiple market capitalizations; it employs a multicap growth strategy focusing on companies with strong earnings growth potential, innovative business models, and competitive advantages in sectors such as technology, healthcare, consumer discretionary, and industrials. The fund offers investors exposure to small-, mid-, and large-cap growth stocks through active management, with holdings selected based on fundamental analysis including revenue growth, earnings quality, and market positioning; it provides daily liquidity, tax efficiency typical of ETFs, and benchmarked performance against indices like the Russell 3000 Growth Index. Headquartered in St. Petersburg, Florida, under the sponsorship of Raymond James Investment Services, Inc., the ETF launched in 2024 and operates primarily in the U.S. market targeting growth-oriented investors including financial advisors, institutions, and retail portfolios. Recent developments include the fund's inaugural full-year performance reporting in late 2025, which highlighted a strategic tilt toward AI-driven technology firms and healthcare innovators amid market volatility; in Q3 2025, RJMG announced portfolio rebalancing to increase allocations to undervalued mid-cap growth names following a partnership with Raymond James' quantitative research team for enhanced stock selection models; additionally, the fund expanded its distribution through new advisor platforms in October 2025, reflecting Raymond James' broader push into ETF offerings as part of its $1.5 billion asset management growth initiative.